Hyperglycemia
Conditions
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects giving written informed consent 2. Healthy men and women of 20 to 64 years age 3. Fasted blood glucose levels were 100 to 125 mg/dL and blood HbA1c levels were 5.6 to 6.4 % at the screening period
Exclusion criteria
Exclusion criteria: 1. Subjects who take the medicine affecting blood glucose levels 2. Subjects with a habit of taking supplements or health food affecting blood glucose levels in one month before the screening test 3. Subjects with a habit of intake more than twice in a week of fermented milk or lactic fermenting beverage in one month before the screening test 4. Subjects with milk allergy 5. Subjects who were diagnosed with diabetes requiring medication by the screening test 6. Sever systemic diseases affecting the results of this study 7. Subjects who have chronic illness and who take medication everyday 8. Subjects who were judged unsuitable as subjects by clinical examination at the screening test 9. Subjects who donated blood of more than 200 mL within a month or more than 400 mL within 3 months 10. Subjects who drink a lot of alcohol 11. Subjects who have been drug dependency or alcohol dependency 12. Subjects who participated in other clinical trials within one month before the agreement of participants in this study 13. Subjects in pregnancy or in nursing 14. Subjects who are judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasted blood glucose, HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasted blood insulin Insulin resistance indexes (HOMA-IR, QUICKI) Glycoalbumin Blood inflammatory cytokines, hsCRP Blood adiponectin Blood lipids | — |
Countries
Japan
Contacts
Public ContactEiji Yoshikawa
KSO Corporation Facility Management Department
Outcome results
None listed